US 12419890
Administration of sumo-activating enzyme inhibitor and checkpoint inhibitors
granted A61KA61K2039/505A61K31/505
Quick answer
US patent 12419890 (Administration of sumo-activating enzyme inhibitor and checkpoint inhibitors) held by Takeda Pharmaceutical Company Limited expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/505, A61K31/505, A61K31/506, A61K39/39558